Showing results (31-40 of 190) with videos related to
Sort By:
Pageof 19
Physiological Genomics|December 8, 2017
Attempted replication of SNPs in RANKL and OPG with musculoskeletal adverse events during aromatase inhibitor treatment for breast cancerJacqueline M Dempsey, Jingyue Xi, N Lynn Henry, et al.The Oncologist|December 10, 2013
Prediction of postchemotherapy ovarian function using markers of ovarian reserveN Lynn Henry, Rong Xia, Anne F Schott, et al.Breast Cancer Research and Treatment|January 9, 2021
Endocrine therapy and radiotherapy use among older women with hormone receptor-positive, clinically node-negative breast cancerMei Wei, Xuechen Wang, Danielle N Zimmerman, et al.Breast Cancer Research and Treatment|November 13, 2022
Association between nociplastic pain and premature endocrine therapy discontinuation in breast cancer patientsElizabeth Joyce, Grant Carr, Sidi Wang, et al.The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|May 9, 2025
Risks of adverse health outcomes among older rural prostate cancer survivors in the SEER-Medicare dataChun-Pin Chang Esther, Daren Huang, Shane Lloyd, et al.Breast Cancer Research and Treatment|March 3, 2017
Identifying socio-demographic and clinical characteristics associated with medication beliefs about aromatase inhibitors among postmenopausal women with breast cancerTeresa M Salgado, Emily J Davis, Karen B Farris, et al.Breast Cancer Research and Treatment|November 19, 2024
Neighborhood socioeconomic deprivation and patient-reported outcomes in symptom management trials for women with breast cancerRiha Vaidya, Cathee Till, N Lynn Henry, et al.Breast Cancer Research and Treatment|June 27, 2022
Co-occurrence and metabolic biomarkers of sensory and motor subtypes of peripheral neuropathy from paclitaxelCiao-Sin Chen, Ellen M Lavoie Smith, Kathleen A Stringer, et al.JAMA Oncology|December 26, 2025
Baseline Fatigue and Severe Toxic Effects in Patients With Cancer Receiving Systemic TherapyJoseph M Unger, Michael J Fisch, Salene M W Jones, et al.Cancer Chemotherapy and Pharmacology|June 5, 2021
Feasibility of pharmacometabolomics to identify potential predictors of paclitaxel pharmacokinetic variabilityLi Chen, Ciao-Sin Chen, Yihan Sun, et al.Pageof 19